The DOI matches its Crossref record; 38 of the 38 references it cites were found in a registry or an index.
A novel transformation suppressor, Pdcd4, inhibits AP-1 transactivation but not NF-κB or ODC transactivation
Abstract
Pdcd4 is a novel transformation suppressor that is highly expressed in promotion-resistant (P-) mouse epidermal JB6 cells but not in susceptible (P+) cells. Overexpression of pdcd4 cDNA in stably transfected P+ cells rendered cells resistant to tumor promoter-induced transformation, indicating that elevated expression of Pdcd4 protein is sufficient to suppress neoplastic transformation. To determine whether Pdcd4 suppresses neoplastic transformation through inhibiting known transformation required events, we examined the possibility that pdcd4 inhibited the activation of AP-1 or NF-kappaB dependent transcription or of ornithine decarboxylase (ODC) activity. Activation of AP-1-dependent transcriptional activity was inhibited by pdcd4 expression in a concentration dependent manner. In contrast, Pdcd4 slightly increased NF-kappaB-dependent transcription and did not alter ODC enzymatic activity. Previous studies suggested that activation of AP-1 was required for P+ cell transformation as well as for tumor promotion in vivo. These results indicate that Pdcd4 functions as a transformation suppressor, possibly through inhibiting AP-1 activation in combination with other factors such as enhancing NF-kappaB activation. Pdcd4 may thus constitute a useful molecular target for cancer prevention.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“PDCD4 does not inhibit NF-κB in mouse JB6 cells where it inhibits AP-1 transactivation and transformation (26).”
From Tumor suppressor PDCD4 inhibits NF-κB-dependent transcription in human glioblastoma cells by direct interaction with p65 (2014) · cites this paper as [26]
Citations
Cites
THE NF-κB AND IκB PROTEINS: New Discoveries and Insights
Baldwin, A. S. (1996) · Annual Review of Immunology · doi:10.1146/annurev.immunol.14.1.649 · Cited by 5,882
Recent advances in the biochemistry of polyamines in eukaryotes
Pegg, A. E. (1986) · Biochemical Journal · doi:10.1042/bj2340249 · Cited by 1,561
Molecular genetics of polyamine synthesis in eukaryotic cells
Heby, O., & Persson, L. (1990) · Trends in Biochemical Sciences · doi:10.1016/0968-0004(90)90216-x · Cited by 523
The role of Jun, Fos and the AP-1 complex in cell-proliferation and transformation
Angel, P., & Karin, M. (1991) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/0304-419x(91)90011-9 · Cited by 450
Seitz, C. S., Lin, Q., Deng, H., & Khavari, P. A. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.5.2307 · Cited by 437
Young, M. R., Li, J. J., Rincón, M., Flavell, R. A., Sathyanarayana, B. K., Hunziker, R., & Colburn, N. H. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.17.9827 · Cited by 387
Self-citationDong, Z., Birrer, M. J., Watts, R. G., Matrisian, L. M., & Colburn, N. H. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.2.609 · Cited by 386
Self-citationTumour promoter induces anchorage independence irreversibly
Colburn, N. H., Former, B. F., Nelson, K. A., & Yuspa, S. H. (1979) · Nature · doi:10.1038/281589a0 · Cited by 284
Self-citationNF-κB to the rescue: RELs, apoptosis and cellular transformation
Foo, S. Y., & Nolan, G. P. (1999) · Trends in Genetics · doi:10.1016/s0168-9525(99)01719-9 · Cited by 279
Hsu, T.-C., Young, M. R., Cmarik, J. L., & Colburn, N. H. (2000) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(00)00220-3 · Cited by 267
Self-citation
Research works printed but not linked: 1
- De Benedetti F, Colburn NH, Oppenheim JJ and Faltynek CR. . 1990). Molecular and Cellular Biology in Cytokines. Oppenheim JJ, Powanda M and Dinarello C . (eds). Wiley-Liss pp. 275–280.
Cited by
Sorted by citations
Items 101–186 of 186
Wei, S., Trempus, C. S., Cannon, R. E., Bortner, C. D., & Tennant, R. W. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m206328200 · Cited by 35
Ma, G., Zhang, H., Dong, M., Zheng, X., Ozaki, I., Matsuhashi, S., & Guo, K. (2013) · Tumor Biology · doi:10.1007/s13277-013-0975-9 · Cited by 34
Pdcd4 protein and mRNA level alterations do not correlate in human lung tumors
Калиниченко, С. В., Kopantzev, E. P., Korobko, E. V., Palgova, I. V., Эдуардовна, З. Л., Mv, B., Petrov, A. N., Frank, G. A., Sverdlov, E. D., & Korobko, I. V. (2008) · Lung Cancer · doi:10.1016/j.lungcan.2008.03.022 · Cited by 33
Yasuda, M., Schmid, T., Rübsamen, D., Colburn, N. H., Irie, K., & Murakami, A. (2010) · Molecular Carcinogenesis · doi:10.1002/mc.20660 · Cited by 33
Self-citationWang, W., Zhang, H., Wang, H., Sun, Y.-G., Peng, Z.-H., Zhou, G., Yang, S., Wang, R., & Fang, D.-C. (2010) · Molecular Diagnosis & Therapy · doi:10.1007/bf03256368 · Cited by 33
Taylor, J. M., Ghorbel, S., & Nicot, C. (2009) · BMC Genomics · doi:10.1186/1471-2164-10-311 · Cited by 32
Mahmoud, E. H., Fawzy, A., & Elshimy, R. A. A. (2018) · Europe PMC (PubMed Central) · doi:10.22034/apjcp.2018.19.1.33 · Cited by 31
Lee, J.-Y., Yun, M., Paik, J., Lee, S., & Yang, S.-W. (2016) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.15-18157 · Cited by 31
Zhu, L., Zhu, Q., Wen, H., Huang, X., & Zheng, G. (2018) · Journal of Cellular Physiology · doi:10.1002/jcp.27561 · Cited by 31
Zhang, H., Xing, Z., Zheng, J., Shi, J., & Cui, C. (2023) · International Immunopharmacology · doi:10.1016/j.intimp.2023.110258 · Cited by 30
Nielsen, B. S., Balslev, E., Poulsen, T. S., Nielsen, D. L., Møller, T., Mortensen, C. E., Holmstrøm, K., & Høgdall, E. V. S. (2014) · Frontiers in Oncology · doi:10.3389/fonc.2014.00207 · Cited by 31
PDCD4 Knockdown Induces Senescence in Hepatoma Cells by Up-Regulating the p21 Expression
Guo, J., Ozaki, I., Xia, J., Kuwashiro, T., Kojima, M., Takahashi, H., Ashida, K., Anzai, K., & Matsuhashi, S. (2019) · Frontiers in Oncology · doi:10.3389/fonc.2018.00661 · Cited by 29
miRNA–mRNA crosstalk in esophageal cancer: From diagnosis to therapy
Sharma, P., & Sharma, R. (2015) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2015.07.002 · Cited by 29
Zhang, Y., Wang, Q., Chen, L., & Yang, H. (2015) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-14-0648 · Cited by 30
Self-citationTargeting translation regulators improves cancer therapy
Jiang, S., Mo, J.-L., Ji, P., Lei, L., Yin, J., Zhou, H., Liu, Z., & Hong, W. (2020) · Genomics · doi:10.1016/j.ygeno.2020.11.011 · Cited by 28
Wang, W., Zhao, J., Wang, H., Yonggang, S., Peng, Z., Zhou, G., Fan, L., Wang, X., Yang, S., Wang, R., et al. (2010) · Experimental Cell Research · doi:10.1016/j.yexcr.2010.05.027 · Cited by 28
Pan, L., Xu, P., Luo, X.-L., Wang, L., Liu, S., Zhu, Y. Z., Hu, J., & Liu, X. (2017) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2017.01.152 · Cited by 28
Lankat–Buttgereit, B., Lenschen, B., Schmidt, H., & Göke, R. (2007) · APOPTOSIS · doi:10.1007/s10495-007-0153-x · Cited by 28
Wang, Q., Zhu, J., Zhang, Y., Sun, Z., Guo, X., Wang, X., Lee, E. Y., Bakthavatchalu, V., Yang, Q., & Yang, H. (2013) · European Journal of Cancer · doi:10.1016/j.ejca.2012.12.014 · Cited by 28
Self-citationKroczyńska, B., Sharma, B., Eklund, E. A., Fish, E. N., & Platanias, L. C. (2012) · Molecular and Cellular Biology · doi:10.1128/mcb.00310-12 · Cited by 27
Cuccarese, M. F., Wang, Y., Beuning, P. J., & O'Doherty, G. A. (2014) · ACS Medicinal Chemistry Letters · doi:10.1021/ml4005039 · Cited by 26
Li, Z.-H., Gao, W., Ho, W.-K., Lei, W. B., Wei, W., Chan, J. Y. W., & Wong, T. (2016) · 癌症:英文版 · doi:10.1186/s40880-016-0158-3 · Cited by 25
Total Synthesis of (+)-Cryptocaryol A Using a Prins Cyclization/Reductive Cleavage Sequence
Brun, E., Bellosta, V., & Cossy, J. (2015) · The Journal of Organic Chemistry · doi:10.1021/acs.joc.5b01323 · Cited by 24
Total Synthesis of Cryptocaryol A by Enantioselective Iridium‐Catalyzed Alcohol C−H Allylation
Perez, F., Waldeck, A. R., & Krische, M. J. (2016) · Angewandte Chemie International Edition · doi:10.1002/anie.201600591 · Cited by 24
Zargar, S., Tomar, V. S., Shyamsundar, V., Ramshankar, V., Somasundaram, K., & Karunagaran, D. (2019) · Molecular and Cellular Biology · doi:10.1128/mcb.00410-18 · Cited by 25
Yasuda, M. T., Nishizawa, T., Ohigashi, H., Tanaka, T., Hou, D., Colburn, N. H., & Murakami, A. (2009) · Carcinogenesis · doi:10.1093/carcin/bgp106 · Cited by 23
Self-citationThe unique evolution of the programmed cell death 4 protein in plants
Cheng, S., Liu, R., & Gallie, D. R. (2013) · BMC Evolutionary Biology · doi:10.1186/1471-2148-13-199 · Cited by 22
Effect of ovarian hormones on survival genes in laser captured serotonin neurons from macaques
Bethea, C. L., & Reddy, A. P. (2008) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2008.05213.x · Cited by 22
Induction of miR-21-PDCD4 signaling by UVB in JB6 cells involves ROS-mediated MAPK pathways
Hou, L., Bowman, L. L., Meighan, T. G., Pratheeshkumar, P., Shi, X., & Ding, M. (2013) · Experimental and Toxicologic Pathology · doi:10.1016/j.etp.2013.05.006 · Cited by 21
Hypermethylation and Expression Silencing of PDCD4 Gene in Hepatocellular Carcinoma
Ding, X., Cheng, X., Gong, M., Chen, X., Yin, F., & Lai, K. (2016) · Medicine · doi:10.1097/md.0000000000002729 · Cited by 22
The function of miRNAs in hepatocarcinogenesis induced by hepatitis B virus X protein
Wang, Z., Wu, Z., & Huang, P. (2017) · Oncology Reports · doi:10.3892/or.2017.5716 · Cited by 22
Grkovic, T., Blees, J., Bayer, M., Colburn, N., Thomas, C., Henrich, C., Peach, M., McMahon, J., Schmid, T., & Gustafson, K. (2014) · Marine Drugs · doi:10.3390/md12084593 · Cited by 20
Self-citationYuan, H., Xin, S., Huang, Y., Bao, Y., Jiang, H., Zhou, L., Ren, X., Li, L., Wang, Q., & Zhang, J. (2017) · Oncology Letters · doi:10.3892/ol.2017.6605 · Cited by 21
Riar, A. K., Narasimhan, M., Rathinam, M. L., Vedpathak, D., Mummidi, S., Henderson, G. I., & Mahimainathan, L. (2014) · PLoS ONE · doi:10.1371/journal.pone.0098080 · Cited by 20
Blees, J. S., Schmid, T., Thomas, C. L., Baker, A. R., Benson, L. C., Evans, J. R., Goncharova, E. I., Colburn, N. H., McMahon, J. B., & Henrich, C. J. (2009) · SLAS DISCOVERY · doi:10.1177/1087057109351028 · Cited by 18
Self-citationZhang, Y., Wang, Q., Guo, X., Miller, R., Guo, Y., & Yang, H. (2011) · Molecular Carcinogenesis · doi:10.1002/mc.20733 · Cited by 17
Self-citationChanges in Translational Control after Pro-Apoptotic Stress
Lasfargues, C., Martineau, Y., Bousquet, C., & Pyronnet, S. (2012) · International Journal of Molecular Sciences · doi:10.3390/ijms14010177 · Cited by 22
Pietrzyk‐Brzezinska, A. J., Panjikar, S., Bujacz, A., Mueller‐Dieckmann, J., Łochyńska, M., Jaskólski, M., & Bujacz, G. (2012) · Acta Crystallographica Section D Biological Crystallography · doi:10.1107/s0907444912021555 · Cited by 16
Zhang, Z., Jin, A., & Yan, D. (2017) · Molecular Medicine Reports · doi:10.3892/mmr.2017.7963 · Cited by 16
Fuchs, T., & Allgayer, H. (2003) · Biological Chemistry · doi:10.1515/bc.2003.084 · Cited by 16
Lee, W.-M., Paik, J., Cho, W., Oh, E., Lee, S., & Yang, S.-W. (2013) · Current Eye Research · doi:10.3109/02713683.2012.750368 · Cited by 15
Pdcd4 tumor suppressor: Properties, functions, and possible applications in oncology
Вихрева, П. Н., Shepelev, M. V., Korobko, E. V., & Korobko, I. V. (2010) · Molecular Genetics Microbiology and Virology · doi:10.3103/s0891416810020011 · Cited by 15
Lim, S., & Hong, R. (2011) · Oncology Letters · doi:10.3892/ol.2011.365 · Cited by 13
Prognostic significance of PDCD4 expression in human salivary adenoid cystic carcinoma
Qi, C., Shao, Y., Li, N., Zhang, C., Zhao, M., & Gao, F. (2013) · Medical Oncology · doi:10.1007/s12032-013-0491-1 · Cited by 14
Ferris, W. F. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.903374 · Cited by 11
Роль мікро-РНК при захворюваннях біліарної системи
Абатуров, А. Е., & Babуch, V. L. (2017) · CHILD`S HEALTH · doi:10.22141/2224-0551.12.7.2017.116191 · Cited by 13
Expression of programmed cell death protein 4 (PDCD4) and miR-21 in urothelial carcinoma
Fischer, N., Göke, F., Splittstößer, V., Lankat–Buttgereit, B., Müller, S. C., & Ellinger, J. (2011) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2011.11.035 · Cited by 11
The Impact of Pdcd4, a Translation Inhibitor, on Drug Resistance
Wang, Q., & Yang, H. (2024) · Pharmaceuticals · doi:10.3390/ph17101396 · Cited by 10
Self-citationZhang, J., Ma, L., Shi, D., Zhang, Z., Yao, C., Zhao, X., Xu, Q., Wen, P., & He, L. (2018) · Journal of Cellular Biochemistry · doi:10.1002/jcb.26672 · Cited by 10
Reconstruction of absent lacrimal puncta.
Putterman, A. M. (1979) · PubMed · Cited by 9
Chen, G., Li, P.-H., He, J., Su, Y., Chen, H.-J., Dong, J., Huang, Y., Huang, X., Jiang, Y., Qin, Q., et al. (2021) · Developmental & Comparative Immunology · doi:10.1016/j.dci.2021.104013 · Cited by 8
The microRNA miR-21 conditions the brain to protect against ischemic and traumatic injuries.
Lopez, M. S., Dempsey, R. J., & Vemuganti, R. (2017) · PubMed · Cited by 8
Maeda, N., Abdullahi, A., Beatty, B., Dhanani, Z., & Adegoke, O. A. J. (2017) · Physiological Reports · doi:10.14814/phy2.13395 · Cited by 6
Xu, Y., Guo, C., Pan, W., Zhao, C., Ding, Y., Xie, X., Wei, Z., Sun, Y., & Yu, C. (2021) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2021.100958 · Cited by 7
p38 regulates the tumor suppressor PDCD4 via the TSC-mTORC1 pathway
Braun, C., Katholnig, K., Kaltenecker, C. C., Linke, M., Sukhbaatar, N., Hengstschläger, M., & Weichhart, T. (2021) · Cell Stress · doi:10.15698/cst2021.12.260 · Cited by 8
Hiraku, Y., Watanabe, J., Kaneko, A., Ichinose, T., & Murata, M. (2021) · Journal of Occupational Health · doi:10.1002/1348-9585.12282 · Cited by 7
Wang, D., Guo, S., Han, S., Xu, N., Guo, J., & Sun, Q. (2013) · International Journal of Oncology · doi:10.3892/ijo.2013.1841 · Cited by 6
Programmed cell death 4 (PDCD4) as a novel prognostic marker for papillary thyroid carcinoma
Galuppini, F., Fassan, M., Bertazza, L., Barollo, S., Cascione, L., Watutantrige‐Fernando, S., Lazzarin, V., Simonato, P., Vianello, F., Rugge, M., et al. (2019) · Cancer Management and Research · doi:10.2147/cmar.s194344 · Cited by 7
Total Synthesis of Cryptocaryol A by Enantioselective Iridium‐Catalyzed Alcohol C−H Allylation
Perez, F., Waldeck, A. R., & Krische, M. J. (2016) · Angewandte Chemie · doi:10.1002/ange.201600591 · Cited by 5
Association of aging with gene expression profiling in mouse submandibular glands
Saito, Y., Yamada, A., Suzuki, D., Tanaka, J., Nagahama, R., Kurosawa, T., Maki, K., Mishima, K., Shirota, T., & Kamijo, R. (2015) · Genomics Data · doi:10.1016/j.gdata.2015.05.012 · Cited by 5
Endocrine Control of Breast Development
Russo, J., & Russo, I. H. (2004) · Springer eBooks · doi:10.1007/978-3-642-18736-0_3 · Cited by 4
Lv, Z., Li, C., Shao, Y., Zhang, W., Wang, Z., & Wang, H. (2016) · Molecular Immunology · doi:10.1016/j.molimm.2016.05.013 · Cited by 4
Wang, Q., He, W., Han, S., Li, M., Wang, Y., Zaytseva, Y. Y., Chen, L., Zhu, J., & Yang, H. (2025) · Cancer Medicine · doi:10.1002/cam4.71145 · Cited by 3
Self-citationTargeting translation initiation in breast cancer
Akçakanat, A., Hong, D. S., & Meric‐Bernstam, F. (2014) · Translation · doi:10.4161/trla.28968 · Cited by 3
The μ-opioid receptor induces miR-21 expression and is ERK/PKCμ-dependent
Chang, J.-K., Cornwell, W. D., & Rogers, T. J. (2021) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2021.577585 · Cited by 3
Low PDCD4 Expression Is Associated With Poor Prognosis of Colorectal Carcinoma
Kim, J. Y., Lee, H., Kim, E., Lee, W. M., Hong, Y. O., & Hong, S. A. (2021) · Applied immunohistochemistry & molecular morphology · doi:10.1097/pai.0000000000000948 · Cited by 3
Yang, H., Wang, Q., Bajer, M. M., & Schmid, T. (2014) · Springer eBooks · doi:10.1007/978-94-017-9078-9_6 · Cited by 3
Self-citationYan, Y., Wang, W., Liu, Z., Lv, X., Li, M., Yang, W., Wang, L., & Song, L. (2020) · Fish & Shellfish Immunology · doi:10.1016/j.fsi.2020.02.038 · Cited by 2
Osoro, E. K., Du, X., Dong, L., Lan, X., Farooq, R., Huang, F., Zhu, W., Ren, J., Sadiq, M., Tian, L., et al. (2021) · Biochemistry and Cell Biology · doi:10.1139/bcb-2021-0028 · Cited by 2
The Role of miR-21, an Androgen-Regulated MicroRNA, in Prostate Cancer
Ribas, J., & Lupold, S. E. (2013) · Springer eBooks · doi:10.1007/978-1-4614-6182-1_18 · Cited by 3
Bacillus anthracis Lethal Toxin Represses MMTV Promoter Activity through Transcription Factors
Kang, Z., Marketon, J. I. W., Johnson, A., & STERNBERG, E. M. (2009) · Journal of Molecular Biology · doi:10.1016/j.jmb.2009.04.030 · Cited by 2
Suliman, B. A. (2025) · Current Issues in Molecular Biology · doi:10.3390/cimb48010022 · Cited by 1
Dezi, V., Harvey, R. F., Smith, T. S., Cole, C. H., Pizzinga, M., Stoneley, M., Garland, G. D., Horvilleur, E., Kalmar, L., Sawarkar, R., et al. (2026) · Nucleic Acids Research · doi:10.1093/nar/gkag071 · Cited by 2
Protein kinase GSK3β regulates tumor suppressor pdcd4 expression in lung cancer cells
Вихрева, П. Н., Korobko, E. V., & Korobko, I. V. (2012) · Doklady Biochemistry and Biophysics · doi:10.1134/s1607672912010176 · Cited by 1
Абатуров, А. Е., & Babуch, V. L. (2024) · CHILD`S HEALTH · doi:10.22141/2224-0551.18.8.2023.1657 · Cited by 1
Leupold, J. H., Colburn, N. H., Yang, H., Lengyel, E. R., Schildberg, F. W., Jauch, K. W., & Allgayer, H. (2003) · Langenbecks Archiv für Chirurgie. Supplement · doi:10.1007/978-3-642-19024-7_20
Self-citationProgrammed Cell Death Protein 4 -Expression in Urologic Tumors
Fischer, N., Göke, F., Kahl, P., Splittstößer, V., Lankat–Buttgereit, B., Müller, S. C., & Ellinger, J. (2014) · The Open Prostate Cancer Journal · doi:10.2174/1876822901407010007
Nuclear Factors Linking Cancer and Inflammation
Chosdol, K., Bhagat, M., Dikshit, B., Madan, E., Chattopadhyay, P., & Sinha, S. (2013) · Cancer drug discovery and develogment/Cancer drug discovery and development · doi:10.1007/978-1-4614-8039-6_6
Fitzgerald, J. B. (2013) · KU ScholarWorks (The University of Kansas)
Jordan, L. E. (2011) · uO Research (University of Ottawa) · doi:10.20381/ruor-4562
Abdel‐Halim, M. R. E., Mohammed, F. N., Sayed, K. S., Abouelfadl, D. M., el Din, A. G., & Badawi, M. (2016) · Journal of the Egyptian Womenʼs Dermatologic Society · doi:10.1097/01.ewx.0000481053.61341.ae
Tomenson, M. (2010) · TSpace (University of Toronto)
miR-21 Expression in Grade I, II, and III Breast Cancer
Juwita, J., Ompusunggu, H. E. S., Nauphar, D., Pardede, S. M., Lim, H., & Siregar, Y. (2016) · Indonesian Journal of Medicine · doi:10.26911/theijmed.2016.01.01.04
Role of PDCD4 in inflammation and tumors: a double-edged sword
Jia, Y., Chen, X., & Zhang, L. (2018) · Scientia Sinica Vitae · doi:10.1360/n052018-00164
Aldinger, J., Roach, K. A., Meighan, T. G., Roberts, J. R., & Barber, T. L. (2024) · Applied In Vitro Toxicology · doi:10.1089/aivt.2024.0034
Metadata
- Authors
- Yang, H.-S., Jansen, A. P., Nair, R., Shibahara, K., Verma, A. K., Cmarik, J. L., & Colburn, N. H.
- Affiliations
- Frederick National Laboratory for Cancer Research (US)
- University of Wisconsin–Madison (US)
- Kyoto University (JP)
- Venue
- Oncogene
- Published
- 2001-02-08
- Volume
- 20
- Issue
- 6
- Pages
- 669-676
- ISSN
- 0950-9232 (ISSN-L)
- 1476-5594
- OpenAlex
- W2093224647
- Cited by
- 185
- References
- 38
- Citations by year
- 2026: 1 · 2025: 2 · 2024: 3 · 2023: 1 · 2022: 1 · 2021: 7 · 2020: 2 · 2019: 5 · 2018: 7 · 2017: 8 · 2016: 8 · 2015: 7 · 2014: 17 · 2013: 17 · 2012: 12
- FWCI
- 2.77
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Oncogene (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Mechanisms of cancer metastasis
- Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Signaling Pathways in Disease
- Keywords
- PDCD4, AP-1 transactivation, NF-κB, ornithine decarboxylase, JB6 epidermal cells, transcriptional regulation, cancer prevention, tumor suppressor
- MeSH terms
- Animals, Cell Transformation, Neoplastic, Ornithine Decarboxylase, Proteins, Tetradecanoylphorbol Acetate, Transcriptional Activation, Genes, Tumor Suppressor, NF-kappa B, RNA-Binding Proteins, Transcription Factor AP-1, Apoptosis Regulatory Proteins, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review